The arthritis drug tocilizumab doesn’t appear to help fight COVID-19

An initial crop of clinical trials testing an anti-inflammatory drug against COVID-19 do not look promising. The best available evidence among these trials “doesn’t show that this drug is beneficial,” says Adarsh Bhimraj, an infectious diseases physician at the Cleveland Clinic, who was not involved in the research. The drug, tocilizumab, is a treatment for […]